0 items USD 0.00Search
- Did you mean
- closing spondylitis
Your search for "Ankylosing%20spondylitis" gave back 267 results.
The global Infliximab Biosimilar market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of %...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis. The “Etanercept...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Summary Antipyretic Analgesics and NSAIDs market research report provides the newest industry data and industry future trends, allowing you to...
Catalog:
ICRW
March 2021
Price: USD 2,960.00
Summary Antipyretic Analgesics and NSAIDs market research report provides the newest industry data and industry future trends, allowing you to...
Catalog:
ICRW
March 2020
Price: USD 2,960.00
Summary Antipyretic Analgesics and NSAIDs market research report provides the newest industry data and industry future trends, allowing you to...
Catalog:
ICRW
March 2019
Price: USD 2,960.00
The global Diclofenac market size was valued at US$ million in 2023. With growing demand in downstream market, the Diclofenac is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Arthritic Therapeutic market size was valued at US$ 26650 million in 2023. With growing demand in downstream market, the Arthritic...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that is mainly employed to treat mild-to-moderate pain & reduces pain, inflammation...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Systemic Autoimmune Disease Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global JAK1 Inhibitors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-...
Catalog:
GIR
August 2023
Price: USD 4,480.00
The global PDE 4 Inhibitors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-...
Catalog:
GIR
August 2023
Price: USD 4,480.00
The global Adalimumab Monoclonal Antibody Biosimilar market size is expected to reach $ 955.4 million by 2029, rising at a market growth of 12.0%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
